Italy’s antitrust regulator, AGCM, has concluded its investigation into the online travel platform Booking.com, determining that commitments offered by the company were sufficient to address the competition concerns initially raised. The decision, announced Thursday, comes months after the probe was launched in March to examine whether the platform abused its dominant position in the hotel booking market, according to Reuters.
The inquiry centered on Booking.com’s management of its Preferred Partner Programme. The AGCM had raised concerns that the programme’s practices could distort competition, particularly by influencing hotel pricing policies. The watchdog suggested that such actions might restrict consumer choice and inflate costs in the market for online hotel booking services across Italy.
Read more: Spain’s Antitrust Watchdog Slaps Booking.com with €413.2 Million Fine for Market Abuses
Per Reuters, Booking.com proposed a series of measures to alleviate these concerns. Among the key commitments, the company assured that hotel prices offered through other online channels would not influence the platform’s decisions when managing or promoting hotels in its Preferred Partner Programme.
The regulator deemed these assurances sufficient to mitigate the potential harm to competition, thereby deciding to close the investigation. While the AGCM will continue to monitor the market, this outcome signals a step forward for Booking.com in addressing regulatory scrutiny of its business practices.
Source: Reuters
Featured News
Federal Judge Dismisses Class Action Alleging Inflated Yacht Commission Fees
Jan 22, 2025 by
CPI
Doug Gurr Appointed Interim Chairman of UK’s Competition Authority
Jan 22, 2025 by
CPI
LinkedIn Faces Lawsuit Over Alleged Misuse of Customer Data for AI Training
Jan 22, 2025 by
Amanda Adams
Johns Hopkins and Caltech Settle for $35.3M in College Price-Fixing Lawsuit
Jan 22, 2025 by
CPI
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan